AAAAAA

   
Results: 1-9 |
Results: 9
Markedly diminished drug resistance-inducing properties of vinflunine (20 ',20 '-difluoro-3 ',4 '-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro
Authors: Etievant, C Kruczynski, A Barret, JM Tait, AS Kavallaris, M Hill, BT
Citation: C. Etievant et al., Markedly diminished drug resistance-inducing properties of vinflunine (20 ',20 '-difluoro-3 ',4 '-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro, CANC CHEMOT, 48(1), 2001, pp. 62-70
Characterization of the biological and biochemical activities of F 11782 and the bisdioxopiperazines, ICRF-187 and ICRF-193, two types of topoisomerase II catalytic inhibitors with distinctive mechanisms of action
Authors: van Hille, B Etievant, C Barret, JM Kruczynski, A Hill, BT
Citation: B. Van Hille et al., Characterization of the biological and biochemical activities of F 11782 and the bisdioxopiperazines, ICRF-187 and ICRF-193, two types of topoisomerase II catalytic inhibitors with distinctive mechanisms of action, ANTI-CANC D, 11(10), 2000, pp. 829-841
F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103
Authors: Etievant, C Kruczynski, A Barret, JM Perrin, D van Hille, B Guminski, Y Hill, BT
Citation: C. Etievant et al., F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103, CANC CHEMOT, 46(2), 2000, pp. 101-113
In vitro synergistic effects of vinflunine, a novel fluorinated vinca alkaloid, in combination with other anticancer drugs
Authors: Barret, JM Etievant, C Hill, BT
Citation: Jm. Barret et al., In vitro synergistic effects of vinflunine, a novel fluorinated vinca alkaloid, in combination with other anticancer drugs, CANC CHEMOT, 45(6), 2000, pp. 471-476
Detection of DNA-strand breaks in cells treated with F 11782, a catalytic inhibitor of topoisomerases I and II
Authors: Barret, JM Montaudon, D Etievant, C Perrin, D Kruczynski, A Robert, J Hill, BT
Citation: Jm. Barret et al., Detection of DNA-strand breaks in cells treated with F 11782, a catalytic inhibitor of topoisomerases I and II, ANTICANC R, 20(6B), 2000, pp. 4557-4562
Characterization of DNA-strand breakage induced in V79 cells by F 11782, acatalytic inhibitor of topoisomerases
Authors: Barret, JM Hill, B Olive, PL
Citation: Jm. Barret et al., Characterization of DNA-strand breakage induced in V79 cells by F 11782, acatalytic inhibitor of topoisomerases, BR J CANC, 83(12), 2000, pp. 1740-1746
F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action
Authors: Perrin, D van Hille, B Barret, JM Kruczynski, A Etievant, C Imbert, T Hill, BT
Citation: D. Perrin et al., F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action, BIOCH PHARM, 59(7), 2000, pp. 807-819
Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells
Authors: Jean-Decoster, C Brichese, L Barret, JM Tollon, Y Kruczynski, A Hill, BT Wright, M
Citation: C. Jean-decoster et al., Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells, ANTI-CANC D, 10(6), 1999, pp. 537-543
Novel artificial endonucleases inhibit base excision repair and potentiatethe cytotoxicity of DNA-damaging agents on L1210 cells
Authors: Barret, JM Etievant, C Fahy, J Lhomme, J Hill, BT
Citation: Jm. Barret et al., Novel artificial endonucleases inhibit base excision repair and potentiatethe cytotoxicity of DNA-damaging agents on L1210 cells, ANTI-CANC D, 10(1), 1999, pp. 55-65
Risultati: 1-9 |